Drug companies have spent $109 million in an effort to defeat a California proposal that would curtain drug spending in the state, The Wall Street Journal reported Thursday.
The measure, named Proposition 61, would require all state agencies to pay the same prices for drugs as the US Department of Veterans Affairs.
Proponents of the proposal argue that the legislation would stop companies from overcharging consumers and taxpayers.
"If we beat the drug industry in California we are going to put them on the defensive and lower the cost of medication across this country," stated US Senator Bernie Sanders.
More than 30 drugmakers, such as Merck & Co. and Pfizer, have contributed to an advertising campaign criticising the measure, asserting that the big could result in higher drug prices by cancelling currently negotiated discounts.
To read more NewsPoints articles, click here.